Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Viatris Readies Restasis Launch – So Where Are The Others?
‘No Remaining Legal Or Regulatory Barriers’ Notes F-T-M Viatris
Feb 07 2022
•
By
Dean Rudge
Viatris/Mylan had worked for "nearly a decade" on its ANDA • Source: Alamy
More from Products
More from Generics Bulletin